LintonPharm Announces First Patient Dosed in Phase 1 Clinical Trial of Catumaxomab for Non-Muscle-Invasive Bladder Cancer Unresponsive to Bacillus Calmette-Guerin
GUANGZHOU, China--(BUSINESS WIRE)--LintonPharm Co., Ltd., a China-based clinical stage biopharmaceutical company focused on the development…